IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate-Reference-Cited by-同舟云学术

IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate

Published:2012-04-26 Issue:5 Volume:42 Page:1337-1353
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Bernardo David¹,Vallejo-Díez Sara²,Mann Elizabeth R.¹,Al-Hassi Hafid O.¹,Martínez-Abad Beatriz²,Montalvillo Enrique²,Tee Cheng T.¹,Murugananthan Aravinth U.¹,Núñez Henar³,Peake Simon T. C.¹,Hart Ailsa L.⁴,Fernández-Salazar Luis⁵,Garrote Jose A.⁶,Arranz Eduardo²,Knight Stella C.¹

Affiliation:

1. Antigen Presentation Research Group, Imperial College London; Northwick Park & St Mark's Campus; Watford Road Harrow United Kingdom

2. Department of Paediatrics & Immunology, Mucosal Immunology Lab, Universidad de Valladolid; IBGM-CSIC, Valladolid; Spain

3. Service of Gastroenterology; Hospital Universitario Rio Hortega; Valladolid Spain

4. Department of Gastroenterology, St Mark's Hospital; North West London Hospitals NHS Trust; Harrow United Kingdom

5. Gastroenterology Service; Hospital Clínico Universitario de Valladolid; Valladolid Spain

6. Genetics and Molecular Biology Lab, Service of Clinical Laboratory; Hospital Universitario Río Hortega; Valladolid Spain

Funder

Marie Curie Intra European Fellowship

St Mark's Hospital Foundation

Brigid Balfour Fund

Junta de Castilla y León

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201142327/fullpdf

Reference57 articles.

1. Anatomical basis of tolerance and immunity to intestinal antigens;Mowat;Nat. Rev. Immunol.,2003

2. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution;Heller;Gastroenterology,2005

3. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases;Strober;Gastroenterology,2011

4. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management;Larsen;Ann. Med.,2010

5. Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?;Veloso;World J. Gastroenterol.,2011

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematically investigate the mechanism underlying the therapeutic effect of Astragalus membranaceus in ulcerative colitis;The American Journal of the Medical Sciences;2024-07

2. Safety, tolerability, and pharmacokinetics of single‐ and multiple‐ascending doses of olamkicept: Results from randomized, placebo‐controlled, first‐in‐human phase I trials;Clinical and Translational Science;2024-05

3. The histamine H4 receptor antagonist 1-[(5-chloro-2,3-dihydro-1-benzofuran-2-yl)methyl]-4-methyl-piperazine(LINS01007) prevents the development of DSS-induced colitis in mice;International Immunopharmacology;2024-05

4. Human-derived bacterial strains mitigate colitis via modulating gut microbiota and repairing intestinal barrier function in mice;BMC Microbiology;2024-03-23

5. Sophocarpine alleviates intestinal fibrosis via inhibition of inflammation and fibroblast into myofibroblast transition by targeting the Sirt1/p65 signaling axis;European Journal of Pharmacology;2024-03